nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—Glyburide—Zafirlukast—asthma	0.294	1	CrCrCtD
Gliclazide—VEGFA—asthma	0.256	0.788	CbGaD
Gliclazide—ALB—asthma	0.0688	0.212	CbGaD
Gliclazide—CYP2C19—Zafirlukast—asthma	0.0186	0.0962	CbGbCtD
Gliclazide—CYP2C19—Formoterol—asthma	0.018	0.0929	CbGbCtD
Gliclazide—CYP2C19—Arformoterol—asthma	0.018	0.0929	CbGbCtD
Gliclazide—CYP2C9—Zileuton—asthma	0.0176	0.0908	CbGbCtD
Gliclazide—CYP2C9—Zafirlukast—asthma	0.0155	0.0799	CbGbCtD
Gliclazide—CYP2C9—Arformoterol—asthma	0.0149	0.0772	CbGbCtD
Gliclazide—CYP2C9—Formoterol—asthma	0.0149	0.0772	CbGbCtD
Gliclazide—CYP2C19—Loratadine—asthma	0.0136	0.0704	CbGbCtD
Gliclazide—CYP2C9—Theophylline—asthma	0.012	0.0617	CbGbCtD
Gliclazide—ALB—Prednisone—asthma	0.0116	0.0602	CbGbCtD
Gliclazide—CYP2C9—Montelukast—asthma	0.0113	0.0585	CbGbCtD
Gliclazide—CYP2C9—Loratadine—asthma	0.0113	0.0585	CbGbCtD
Gliclazide—CYP2C19—Prednisone—asthma	0.00755	0.039	CbGbCtD
Gliclazide—CYP2C19—Dexamethasone—asthma	0.00471	0.0243	CbGbCtD
Gliclazide—CYP2C9—Dexamethasone—asthma	0.00392	0.0202	CbGbCtD
Gliclazide—VEGFA—Glyburide—Zafirlukast—asthma	0.000819	0.325	CbGdCrCtD
Gliclazide—VEGFA—adrenal cortex—asthma	0.00079	0.115	CbGeAlD
Gliclazide—VEGFA—bronchus—asthma	0.000775	0.113	CbGeAlD
Gliclazide—VEGFA—smooth muscle tissue—asthma	0.000758	0.111	CbGeAlD
Gliclazide—VEGFA—trachea—asthma	0.000696	0.102	CbGeAlD
Gliclazide—VEGFA—adrenal gland—asthma	0.00057	0.0833	CbGeAlD
Gliclazide—KCNJ11—cardiovascular system—asthma	0.000516	0.0754	CbGeAlD
Gliclazide—VEGFA—lung—asthma	0.0005	0.073	CbGeAlD
Gliclazide—ABCC8—smooth muscle tissue—asthma	0.000499	0.073	CbGeAlD
Gliclazide—ABCC8—cardiovascular system—asthma	0.000475	0.0694	CbGeAlD
Gliclazide—KCNJ11—adrenal gland—asthma	0.000408	0.0596	CbGeAlD
Gliclazide—ABCC8—adrenal gland—asthma	0.000376	0.0549	CbGeAlD
Gliclazide—ALB—adrenal gland—asthma	0.000269	0.0393	CbGeAlD
Gliclazide—VEGFA—Pindolol—Isoprenaline—asthma	0.000226	0.0898	CbGdCrCtD
Gliclazide—CYP2C9—cardiovascular system—asthma	0.000212	0.031	CbGeAlD
Gliclazide—VEGFA—Betamethasone—Fluticasone furoate—asthma	0.000117	0.0464	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Fluticasone furoate—asthma	0.000117	0.0464	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Fluticasone Propionate—asthma	0.000109	0.0433	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Fluticasone Propionate—asthma	0.000109	0.0433	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Beclomethasone—asthma	8.02e-05	0.0318	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Beclomethasone—asthma	8.02e-05	0.0318	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Budesonide—asthma	7.69e-05	0.0305	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Budesonide—asthma	7.69e-05	0.0305	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Flunisolide—asthma	7.59e-05	0.0301	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Flunisolide—asthma	7.59e-05	0.0301	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Mometasone—asthma	6.22e-05	0.0247	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Mometasone—asthma	6.22e-05	0.0247	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Hydrocortisone—asthma	3.94e-05	0.0156	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Hydrocortisone—asthma	3.94e-05	0.0156	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Methylprednisolone—asthma	3.71e-05	0.0147	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Methylprednisolone—asthma	3.71e-05	0.0147	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Betamethasone—asthma	3.65e-05	0.0145	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Dexamethasone—asthma	3.65e-05	0.0145	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Triamcinolone—asthma	3.57e-05	0.0142	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Triamcinolone—asthma	3.57e-05	0.0142	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Prednisone—asthma	3.39e-05	0.0135	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Prednisone—asthma	3.39e-05	0.0135	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Prednisolone—asthma	3.31e-05	0.0131	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Prednisolone—asthma	3.31e-05	0.0131	CbGdCrCtD
Gliclazide—Loss of consciousness—Prednisolone—asthma	2.53e-05	0.000187	CcSEcCtD
Gliclazide—Nausea—Montelukast—asthma	2.52e-05	0.000186	CcSEcCtD
Gliclazide—Vomiting—Budesonide—asthma	2.52e-05	0.000186	CcSEcCtD
Gliclazide—Rash—Budesonide—asthma	2.5e-05	0.000185	CcSEcCtD
Gliclazide—Dermatitis—Budesonide—asthma	2.5e-05	0.000185	CcSEcCtD
Gliclazide—Convulsion—Prednisolone—asthma	2.5e-05	0.000184	CcSEcCtD
Gliclazide—Headache—Budesonide—asthma	2.49e-05	0.000184	CcSEcCtD
Gliclazide—Hypertension—Prednisolone—asthma	2.49e-05	0.000184	CcSEcCtD
Gliclazide—Loss of consciousness—Hydrocortisone—asthma	2.47e-05	0.000183	CcSEcCtD
Gliclazide—Arrhythmia—Dexamethasone—asthma	2.47e-05	0.000182	CcSEcCtD
Gliclazide—Arrhythmia—Betamethasone—asthma	2.47e-05	0.000182	CcSEcCtD
Gliclazide—Ill-defined disorder—Triamcinolone—asthma	2.46e-05	0.000181	CcSEcCtD
Gliclazide—Ill-defined disorder—Methylprednisolone—asthma	2.45e-05	0.000181	CcSEcCtD
Gliclazide—Bradycardia—Prednisone—asthma	2.45e-05	0.000181	CcSEcCtD
Gliclazide—Convulsion—Hydrocortisone—asthma	2.44e-05	0.00018	CcSEcCtD
Gliclazide—Nausea—Salbutamol—asthma	2.43e-05	0.00018	CcSEcCtD
Gliclazide—Hypertension—Hydrocortisone—asthma	2.43e-05	0.000179	CcSEcCtD
Gliclazide—Discomfort—Prednisolone—asthma	2.42e-05	0.000179	CcSEcCtD
Gliclazide—Angioedema—Triamcinolone—asthma	2.42e-05	0.000179	CcSEcCtD
Gliclazide—Angioedema—Methylprednisolone—asthma	2.41e-05	0.000178	CcSEcCtD
Gliclazide—Erythema—Dexamethasone—asthma	2.4e-05	0.000177	CcSEcCtD
Gliclazide—Erythema—Betamethasone—asthma	2.4e-05	0.000177	CcSEcCtD
Gliclazide—Myalgia—Hydrocortisone—asthma	2.39e-05	0.000177	CcSEcCtD
Gliclazide—Malaise—Triamcinolone—asthma	2.39e-05	0.000176	CcSEcCtD
Gliclazide—Anxiety—Hydrocortisone—asthma	2.39e-05	0.000176	CcSEcCtD
Gliclazide—Malaise—Methylprednisolone—asthma	2.38e-05	0.000176	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	2.38e-05	0.000176	CcSEcCtD
Gliclazide—Discomfort—Hydrocortisone—asthma	2.37e-05	0.000175	CcSEcCtD
Gliclazide—Nausea—Budesonide—asthma	2.36e-05	0.000174	CcSEcCtD
Gliclazide—Loss of consciousness—Triamcinolone—asthma	2.33e-05	0.000172	CcSEcCtD
Gliclazide—Loss of consciousness—Methylprednisolone—asthma	2.32e-05	0.000172	CcSEcCtD
Gliclazide—Cough—Triamcinolone—asthma	2.31e-05	0.000171	CcSEcCtD
Gliclazide—Convulsion—Triamcinolone—asthma	2.29e-05	0.000169	CcSEcCtD
Gliclazide—Tachycardia—Prednisolone—asthma	2.29e-05	0.000169	CcSEcCtD
Gliclazide—Convulsion—Methylprednisolone—asthma	2.29e-05	0.000169	CcSEcCtD
Gliclazide—Hypertension—Triamcinolone—asthma	2.29e-05	0.000169	CcSEcCtD
Gliclazide—Hypertension—Methylprednisolone—asthma	2.28e-05	0.000168	CcSEcCtD
Gliclazide—Infection—Hydrocortisone—asthma	2.28e-05	0.000168	CcSEcCtD
Gliclazide—Hyperhidrosis—Prednisolone—asthma	2.27e-05	0.000168	CcSEcCtD
Gliclazide—Myalgia—Triamcinolone—asthma	2.25e-05	0.000167	CcSEcCtD
Gliclazide—Nervous system disorder—Hydrocortisone—asthma	2.25e-05	0.000166	CcSEcCtD
Gliclazide—Arthralgia—Methylprednisolone—asthma	2.25e-05	0.000166	CcSEcCtD
Gliclazide—Myalgia—Methylprednisolone—asthma	2.25e-05	0.000166	CcSEcCtD
Gliclazide—Eye disorder—Prednisone—asthma	2.25e-05	0.000166	CcSEcCtD
Gliclazide—Anxiety—Methylprednisolone—asthma	2.24e-05	0.000166	CcSEcCtD
Gliclazide—Tachycardia—Hydrocortisone—asthma	2.24e-05	0.000165	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.23e-05	0.000165	CcSEcCtD
Gliclazide—Flushing—Prednisone—asthma	2.23e-05	0.000165	CcSEcCtD
Gliclazide—Skin disorder—Hydrocortisone—asthma	2.23e-05	0.000165	CcSEcCtD
Gliclazide—Ill-defined disorder—Betamethasone—asthma	2.23e-05	0.000165	CcSEcCtD
Gliclazide—Ill-defined disorder—Dexamethasone—asthma	2.23e-05	0.000165	CcSEcCtD
Gliclazide—Discomfort—Triamcinolone—asthma	2.23e-05	0.000165	CcSEcCtD
Gliclazide—Discomfort—Methylprednisolone—asthma	2.22e-05	0.000164	CcSEcCtD
Gliclazide—Hyperhidrosis—Hydrocortisone—asthma	2.22e-05	0.000164	CcSEcCtD
Gliclazide—Dry mouth—Triamcinolone—asthma	2.21e-05	0.000163	CcSEcCtD
Gliclazide—Angioedema—Betamethasone—asthma	2.2e-05	0.000162	CcSEcCtD
Gliclazide—Angioedema—Dexamethasone—asthma	2.2e-05	0.000162	CcSEcCtD
Gliclazide—Confusional state—Methylprednisolone—asthma	2.17e-05	0.000161	CcSEcCtD
Gliclazide—Malaise—Betamethasone—asthma	2.17e-05	0.00016	CcSEcCtD
Gliclazide—Malaise—Dexamethasone—asthma	2.17e-05	0.00016	CcSEcCtD
Gliclazide—Arrhythmia—Prednisone—asthma	2.15e-05	0.000159	CcSEcCtD
Gliclazide—Infection—Triamcinolone—asthma	2.15e-05	0.000159	CcSEcCtD
Gliclazide—Hypotension—Hydrocortisone—asthma	2.14e-05	0.000158	CcSEcCtD
Gliclazide—Infection—Methylprednisolone—asthma	2.14e-05	0.000158	CcSEcCtD
Gliclazide—Insomnia—Prednisolone—asthma	2.13e-05	0.000157	CcSEcCtD
Gliclazide—Nervous system disorder—Methylprednisolone—asthma	2.11e-05	0.000156	CcSEcCtD
Gliclazide—Loss of consciousness—Betamethasone—asthma	2.11e-05	0.000156	CcSEcCtD
Gliclazide—Loss of consciousness—Dexamethasone—asthma	2.11e-05	0.000156	CcSEcCtD
Gliclazide—Paraesthesia—Prednisolone—asthma	2.11e-05	0.000156	CcSEcCtD
Gliclazide—Tachycardia—Triamcinolone—asthma	2.11e-05	0.000156	CcSEcCtD
Gliclazide—Mental disorder—Prednisone—asthma	2.11e-05	0.000156	CcSEcCtD
Gliclazide—Tachycardia—Methylprednisolone—asthma	2.1e-05	0.000155	CcSEcCtD
Gliclazide—Skin disorder—Methylprednisolone—asthma	2.09e-05	0.000155	CcSEcCtD
Gliclazide—Malnutrition—Prednisone—asthma	2.09e-05	0.000155	CcSEcCtD
Gliclazide—Erythema—Prednisone—asthma	2.09e-05	0.000155	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Hydrocortisone—asthma	2.09e-05	0.000154	CcSEcCtD
Gliclazide—Hyperhidrosis—Triamcinolone—asthma	2.09e-05	0.000154	CcSEcCtD
Gliclazide—Hyperhidrosis—Methylprednisolone—asthma	2.08e-05	0.000154	CcSEcCtD
Gliclazide—Convulsion—Dexamethasone—asthma	2.08e-05	0.000154	CcSEcCtD
Gliclazide—Convulsion—Betamethasone—asthma	2.08e-05	0.000154	CcSEcCtD
Gliclazide—Insomnia—Hydrocortisone—asthma	2.08e-05	0.000153	CcSEcCtD
Gliclazide—Hypertension—Dexamethasone—asthma	2.07e-05	0.000153	CcSEcCtD
Gliclazide—Hypertension—Betamethasone—asthma	2.07e-05	0.000153	CcSEcCtD
Gliclazide—Paraesthesia—Hydrocortisone—asthma	2.06e-05	0.000152	CcSEcCtD
Gliclazide—Myalgia—Betamethasone—asthma	2.05e-05	0.000151	CcSEcCtD
Gliclazide—Myalgia—Dexamethasone—asthma	2.05e-05	0.000151	CcSEcCtD
Gliclazide—Anxiety—Betamethasone—asthma	2.04e-05	0.000151	CcSEcCtD
Gliclazide—Anxiety—Dexamethasone—asthma	2.04e-05	0.000151	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—GSTT1—asthma	2.03e-05	0.00047	CbGpPWpGaD
Gliclazide—CYP2C9—Metapathway biotransformation—GSTM1—asthma	2.03e-05	0.00047	CbGpPWpGaD
Gliclazide—Discomfort—Betamethasone—asthma	2.02e-05	0.000149	CcSEcCtD
Gliclazide—Discomfort—Dexamethasone—asthma	2.02e-05	0.000149	CcSEcCtD
Gliclazide—Dyspepsia—Hydrocortisone—asthma	2.02e-05	0.000149	CcSEcCtD
Gliclazide—Hypotension—Methylprednisolone—asthma	2.02e-05	0.000149	CcSEcCtD
Gliclazide—Pain—Prednisolone—asthma	2.01e-05	0.000148	CcSEcCtD
Gliclazide—ALB—Hemostasis—MYB—asthma	1.98e-05	0.000459	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2RB—asthma	1.98e-05	0.000459	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Hydrocortisone—asthma	1.98e-05	0.000146	CcSEcCtD
Gliclazide—Fatigue—Hydrocortisone—asthma	1.98e-05	0.000146	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—CCR4—asthma	1.98e-05	0.000458	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Triamcinolone—asthma	1.97e-05	0.000145	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Methylprednisolone—asthma	1.96e-05	0.000145	CcSEcCtD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—asthma	1.96e-05	0.000454	CbGpPWpGaD
Gliclazide—Pain—Hydrocortisone—asthma	1.96e-05	0.000145	CcSEcCtD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CHAT—asthma	1.96e-05	0.000452	CbGpPWpGaD
Gliclazide—Insomnia—Triamcinolone—asthma	1.95e-05	0.000144	CcSEcCtD
Gliclazide—Insomnia—Methylprednisolone—asthma	1.95e-05	0.000144	CcSEcCtD
Gliclazide—Infection—Dexamethasone—asthma	1.95e-05	0.000144	CcSEcCtD
Gliclazide—Infection—Betamethasone—asthma	1.95e-05	0.000144	CcSEcCtD
Gliclazide—Ill-defined disorder—Prednisone—asthma	1.94e-05	0.000143	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—SERPINE1—asthma	1.94e-05	0.000449	CbGpPWpGaD
Gliclazide—Paraesthesia—Triamcinolone—asthma	1.94e-05	0.000143	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—STAT6—asthma	1.94e-05	0.000449	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—ALB—asthma	1.94e-05	0.000448	CbGpPWpGaD
Gliclazide—Feeling abnormal—Prednisolone—asthma	1.94e-05	0.000143	CcSEcCtD
Gliclazide—Paraesthesia—Methylprednisolone—asthma	1.94e-05	0.000143	CcSEcCtD
Gliclazide—Anaemia—Prednisone—asthma	1.93e-05	0.000143	CcSEcCtD
Gliclazide—Dyspnoea—Triamcinolone—asthma	1.93e-05	0.000142	CcSEcCtD
Gliclazide—Nervous system disorder—Dexamethasone—asthma	1.92e-05	0.000142	CcSEcCtD
Gliclazide—Nervous system disorder—Betamethasone—asthma	1.92e-05	0.000142	CcSEcCtD
Gliclazide—Agitation—Prednisone—asthma	1.92e-05	0.000142	CcSEcCtD
Gliclazide—Thrombocytopenia—Betamethasone—asthma	1.92e-05	0.000142	CcSEcCtD
Gliclazide—Thrombocytopenia—Dexamethasone—asthma	1.92e-05	0.000142	CcSEcCtD
Gliclazide—Tachycardia—Betamethasone—asthma	1.91e-05	0.000141	CcSEcCtD
Gliclazide—Tachycardia—Dexamethasone—asthma	1.91e-05	0.000141	CcSEcCtD
Gliclazide—Angioedema—Prednisone—asthma	1.91e-05	0.000141	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—RHOA—asthma	1.91e-05	0.000442	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2RB—asthma	1.9e-05	0.000441	CbGpPWpGaD
Gliclazide—Dyspepsia—Triamcinolone—asthma	1.9e-05	0.000141	CcSEcCtD
Gliclazide—Dyspepsia—Methylprednisolone—asthma	1.9e-05	0.00014	CcSEcCtD
Gliclazide—Hyperhidrosis—Dexamethasone—asthma	1.9e-05	0.00014	CcSEcCtD
Gliclazide—Hyperhidrosis—Betamethasone—asthma	1.9e-05	0.00014	CcSEcCtD
Gliclazide—ALB—Platelet degranulation—TGFB1—asthma	1.89e-05	0.000438	CbGpPWpGaD
Gliclazide—Feeling abnormal—Hydrocortisone—asthma	1.89e-05	0.00014	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—PDE4D—asthma	1.89e-05	0.000437	CbGpPWpGaD
Gliclazide—Malaise—Prednisone—asthma	1.89e-05	0.000139	CcSEcCtD
Gliclazide—Gastrointestinal pain—Hydrocortisone—asthma	1.88e-05	0.000139	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—RHOA—asthma	1.87e-05	0.000433	CbGpPWpGaD
Gliclazide—Urticaria—Prednisolone—asthma	1.87e-05	0.000138	CcSEcCtD
Gliclazide—Fatigue—Triamcinolone—asthma	1.86e-05	0.000138	CcSEcCtD
Gliclazide—Fatigue—Methylprednisolone—asthma	1.86e-05	0.000137	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—NOS3—asthma	1.85e-05	0.000429	CbGpPWpGaD
Gliclazide—Pain—Triamcinolone—asthma	1.85e-05	0.000136	CcSEcCtD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	1.84e-05	0.000426	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—asthma	1.84e-05	0.000426	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—C5—asthma	1.84e-05	0.000426	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PDE4B—asthma	1.84e-05	0.000426	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TACR1—asthma	1.84e-05	0.000426	CbGpPWpGaD
Gliclazide—Loss of consciousness—Prednisone—asthma	1.84e-05	0.000136	CcSEcCtD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ALB—asthma	1.84e-05	0.000425	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2RA—asthma	1.83e-05	0.000424	CbGpPWpGaD
Gliclazide—Hypotension—Dexamethasone—asthma	1.83e-05	0.000135	CcSEcCtD
Gliclazide—Hypotension—Betamethasone—asthma	1.83e-05	0.000135	CcSEcCtD
Gliclazide—Urticaria—Hydrocortisone—asthma	1.82e-05	0.000135	CcSEcCtD
Gliclazide—Body temperature increased—Hydrocortisone—asthma	1.81e-05	0.000134	CcSEcCtD
Gliclazide—Abdominal pain—Hydrocortisone—asthma	1.81e-05	0.000134	CcSEcCtD
Gliclazide—Convulsion—Prednisone—asthma	1.81e-05	0.000134	CcSEcCtD
Gliclazide—Hypertension—Prednisone—asthma	1.81e-05	0.000133	CcSEcCtD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—asthma	1.8e-05	0.000417	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SERPINA1—asthma	1.8e-05	0.000416	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Betamethasone—asthma	1.79e-05	0.000132	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Dexamethasone—asthma	1.79e-05	0.000132	CcSEcCtD
Gliclazide—Arthralgia—Prednisone—asthma	1.78e-05	0.000132	CcSEcCtD
Gliclazide—Myalgia—Prednisone—asthma	1.78e-05	0.000132	CcSEcCtD
Gliclazide—Feeling abnormal—Triamcinolone—asthma	1.78e-05	0.000132	CcSEcCtD
Gliclazide—Feeling abnormal—Methylprednisolone—asthma	1.78e-05	0.000131	CcSEcCtD
Gliclazide—Anxiety—Prednisone—asthma	1.78e-05	0.000131	CcSEcCtD
Gliclazide—Insomnia—Dexamethasone—asthma	1.77e-05	0.000131	CcSEcCtD
Gliclazide—Insomnia—Betamethasone—asthma	1.77e-05	0.000131	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PDGFB—asthma	1.77e-05	0.00041	CbGpPWpGaD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.77e-05	0.000131	CcSEcCtD
Gliclazide—Gastrointestinal pain—Methylprednisolone—asthma	1.76e-05	0.00013	CcSEcCtD
Gliclazide—Paraesthesia—Betamethasone—asthma	1.76e-05	0.00013	CcSEcCtD
Gliclazide—Paraesthesia—Dexamethasone—asthma	1.76e-05	0.00013	CcSEcCtD
Gliclazide—Discomfort—Prednisone—asthma	1.76e-05	0.00013	CcSEcCtD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—asthma	1.76e-05	0.000406	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.74e-05	0.000403	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NQO1—asthma	1.74e-05	0.000403	CbGpPWpGaD
Gliclazide—Hypersensitivity—Prednisolone—asthma	1.73e-05	0.000128	CcSEcCtD
Gliclazide—Dyspepsia—Dexamethasone—asthma	1.73e-05	0.000127	CcSEcCtD
Gliclazide—Dyspepsia—Betamethasone—asthma	1.73e-05	0.000127	CcSEcCtD
Gliclazide—Urticaria—Triamcinolone—asthma	1.72e-05	0.000127	CcSEcCtD
Gliclazide—VEGFA—Axon guidance—EGFR—asthma	1.72e-05	0.000397	CbGpPWpGaD
Gliclazide—Urticaria—Methylprednisolone—asthma	1.71e-05	0.000127	CcSEcCtD
Gliclazide—Body temperature increased—Triamcinolone—asthma	1.71e-05	0.000126	CcSEcCtD
Gliclazide—Abdominal pain—Methylprednisolone—asthma	1.7e-05	0.000126	CcSEcCtD
Gliclazide—ABCC8—Metabolism—ADCY2—asthma	1.7e-05	0.000394	CbGpPWpGaD
Gliclazide—Infection—Prednisone—asthma	1.7e-05	0.000125	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Dexamethasone—asthma	1.69e-05	0.000125	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Betamethasone—asthma	1.69e-05	0.000125	CcSEcCtD
Gliclazide—Hypersensitivity—Hydrocortisone—asthma	1.69e-05	0.000125	CcSEcCtD
Gliclazide—Fatigue—Betamethasone—asthma	1.69e-05	0.000125	CcSEcCtD
Gliclazide—Fatigue—Dexamethasone—asthma	1.69e-05	0.000125	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—NQO1—asthma	1.69e-05	0.000391	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCR3—asthma	1.68e-05	0.000389	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	1.68e-05	0.000388	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	1.68e-05	0.000388	CbGpPWpGaD
Gliclazide—Pain—Betamethasone—asthma	1.68e-05	0.000124	CcSEcCtD
Gliclazide—Pain—Dexamethasone—asthma	1.68e-05	0.000124	CcSEcCtD
Gliclazide—ALB—Metabolism—LTC4S—asthma	1.68e-05	0.000388	CbGpPWpGaD
Gliclazide—Nervous system disorder—Prednisone—asthma	1.67e-05	0.000124	CcSEcCtD
Gliclazide—Tachycardia—Prednisone—asthma	1.67e-05	0.000123	CcSEcCtD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CARM1—asthma	1.66e-05	0.000385	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—asthma	1.66e-05	0.000385	CbGpPWpGaD
Gliclazide—Skin disorder—Prednisone—asthma	1.66e-05	0.000123	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—ADCY2—asthma	1.65e-05	0.000382	CbGpPWpGaD
Gliclazide—Hyperhidrosis—Prednisone—asthma	1.65e-05	0.000122	CcSEcCtD
Gliclazide—Asthenia—Hydrocortisone—asthma	1.65e-05	0.000122	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—NPY—asthma	1.64e-05	0.000379	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—asthma	1.64e-05	0.000379	CbGpPWpGaD
Gliclazide—Pruritus—Hydrocortisone—asthma	1.62e-05	0.00012	CcSEcCtD
Gliclazide—Feeling abnormal—Dexamethasone—asthma	1.62e-05	0.000119	CcSEcCtD
Gliclazide—Feeling abnormal—Betamethasone—asthma	1.62e-05	0.000119	CcSEcCtD
Gliclazide—Gastrointestinal pain—Dexamethasone—asthma	1.6e-05	0.000118	CcSEcCtD
Gliclazide—Gastrointestinal pain—Betamethasone—asthma	1.6e-05	0.000118	CcSEcCtD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	1.6e-05	0.00037	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—FN1—asthma	1.6e-05	0.000369	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—POMC—asthma	1.6e-05	0.000369	CbGpPWpGaD
Gliclazide—Hypersensitivity—Triamcinolone—asthma	1.59e-05	0.000118	CcSEcCtD
Gliclazide—Hypersensitivity—Methylprednisolone—asthma	1.59e-05	0.000117	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—AGTR2—asthma	1.58e-05	0.000366	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—CARM1—asthma	1.58e-05	0.000366	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2—asthma	1.57e-05	0.000363	CbGpPWpGaD
Gliclazide—Diarrhoea—Hydrocortisone—asthma	1.57e-05	0.000116	CcSEcCtD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.56e-05	0.000362	CbGpPWpGaD
Gliclazide—Urticaria—Betamethasone—asthma	1.56e-05	0.000115	CcSEcCtD
Gliclazide—Urticaria—Dexamethasone—asthma	1.56e-05	0.000115	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Prednisone—asthma	1.56e-05	0.000115	CcSEcCtD
Gliclazide—Dizziness—Prednisolone—asthma	1.55e-05	0.000115	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—IL6—asthma	1.55e-05	0.000359	CbGpPWpGaD
Gliclazide—Asthenia—Triamcinolone—asthma	1.55e-05	0.000115	CcSEcCtD
Gliclazide—Body temperature increased—Dexamethasone—asthma	1.55e-05	0.000114	CcSEcCtD
Gliclazide—Abdominal pain—Dexamethasone—asthma	1.55e-05	0.000114	CcSEcCtD
Gliclazide—Abdominal pain—Betamethasone—asthma	1.55e-05	0.000114	CcSEcCtD
Gliclazide—Body temperature increased—Betamethasone—asthma	1.55e-05	0.000114	CcSEcCtD
Gliclazide—Asthenia—Methylprednisolone—asthma	1.55e-05	0.000114	CcSEcCtD
Gliclazide—Insomnia—Prednisone—asthma	1.54e-05	0.000114	CcSEcCtD
Gliclazide—Paraesthesia—Prednisone—asthma	1.53e-05	0.000113	CcSEcCtD
Gliclazide—ALB—Hemostasis—GATA3—asthma	1.53e-05	0.000354	CbGpPWpGaD
Gliclazide—Pruritus—Triamcinolone—asthma	1.53e-05	0.000113	CcSEcCtD
Gliclazide—Pruritus—Methylprednisolone—asthma	1.53e-05	0.000113	CcSEcCtD
Gliclazide—Dizziness—Hydrocortisone—asthma	1.52e-05	0.000112	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—MMP9—asthma	1.52e-05	0.000351	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EDNRB—asthma	1.51e-05	0.00035	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LTC4S—asthma	1.51e-05	0.000348	CbGpPWpGaD
Gliclazide—Dyspepsia—Prednisone—asthma	1.5e-05	0.000111	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—NPS—asthma	1.5e-05	0.000347	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TAC1—asthma	1.5e-05	0.000347	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—asthma	1.49e-05	0.000345	CbGpPWpGaD
Gliclazide—Rash—Prednisolone—asthma	1.48e-05	0.000109	CcSEcCtD
Gliclazide—Dermatitis—Prednisolone—asthma	1.48e-05	0.000109	CcSEcCtD
Gliclazide—Diarrhoea—Methylprednisolone—asthma	1.48e-05	0.000109	CcSEcCtD
Gliclazide—Fatigue—Prednisone—asthma	1.47e-05	0.000109	CcSEcCtD
Gliclazide—Headache—Prednisolone—asthma	1.47e-05	0.000109	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—CXCR3—asthma	1.47e-05	0.00034	CbGpPWpGaD
Gliclazide—Constipation—Prednisone—asthma	1.46e-05	0.000108	CcSEcCtD
Gliclazide—Vomiting—Hydrocortisone—asthma	1.46e-05	0.000108	CcSEcCtD
Gliclazide—CYP2C9—Biological oxidations—POMC—asthma	1.46e-05	0.000337	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LTA4H—asthma	1.45e-05	0.000336	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GSTP1—asthma	1.45e-05	0.000336	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL5—asthma	1.45e-05	0.000336	CbGpPWpGaD
Gliclazide—Rash—Hydrocortisone—asthma	1.45e-05	0.000107	CcSEcCtD
Gliclazide—Dermatitis—Hydrocortisone—asthma	1.45e-05	0.000107	CcSEcCtD
Gliclazide—Headache—Hydrocortisone—asthma	1.44e-05	0.000106	CcSEcCtD
Gliclazide—ABCC8—Metabolism—HMOX1—asthma	1.43e-05	0.000331	CbGpPWpGaD
Gliclazide—Dizziness—Triamcinolone—asthma	1.43e-05	0.000106	CcSEcCtD
Gliclazide—ABCC8—Metabolism—ITPR1—asthma	1.43e-05	0.000331	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.43e-05	0.00033	CbGpPWpGaD
Gliclazide—Dizziness—Methylprednisolone—asthma	1.43e-05	0.000105	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—CYBA—asthma	1.42e-05	0.000329	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CAT—asthma	1.41e-05	0.000327	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GSTP1—asthma	1.41e-05	0.000326	CbGpPWpGaD
Gliclazide—Feeling abnormal—Prednisone—asthma	1.41e-05	0.000104	CcSEcCtD
Gliclazide—Asthenia—Betamethasone—asthma	1.41e-05	0.000104	CcSEcCtD
Gliclazide—Asthenia—Dexamethasone—asthma	1.41e-05	0.000104	CcSEcCtD
Gliclazide—Gastrointestinal pain—Prednisone—asthma	1.4e-05	0.000103	CcSEcCtD
Gliclazide—Nausea—Prednisolone—asthma	1.4e-05	0.000103	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—PARP1—asthma	1.39e-05	0.000322	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL5—asthma	1.39e-05	0.000322	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—HMOX1—asthma	1.39e-05	0.000321	CbGpPWpGaD
Gliclazide—Pruritus—Betamethasone—asthma	1.39e-05	0.000102	CcSEcCtD
Gliclazide—Pruritus—Dexamethasone—asthma	1.39e-05	0.000102	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—ITPR1—asthma	1.39e-05	0.00032	CbGpPWpGaD
Gliclazide—Vomiting—Triamcinolone—asthma	1.37e-05	0.000101	CcSEcCtD
Gliclazide—CYP2C9—Metabolism—LTC4S—asthma	1.37e-05	0.000318	CbGpPWpGaD
Gliclazide—Vomiting—Methylprednisolone—asthma	1.37e-05	0.000101	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—CAT—asthma	1.37e-05	0.000317	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS1—asthma	1.36e-05	0.000316	CbGpPWpGaD
Gliclazide—Nausea—Hydrocortisone—asthma	1.36e-05	0.000101	CcSEcCtD
Gliclazide—Rash—Triamcinolone—asthma	1.36e-05	0.000101	CcSEcCtD
Gliclazide—Dermatitis—Triamcinolone—asthma	1.36e-05	0.000101	CcSEcCtD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	1.36e-05	0.000315	CbGpPWpGaD
Gliclazide—Rash—Methylprednisolone—asthma	1.36e-05	0.0001	CcSEcCtD
Gliclazide—Dermatitis—Methylprednisolone—asthma	1.36e-05	0.0001	CcSEcCtD
Gliclazide—Urticaria—Prednisone—asthma	1.36e-05	0.0001	CcSEcCtD
Gliclazide—Headache—Triamcinolone—asthma	1.35e-05	0.0001	CcSEcCtD
Gliclazide—Headache—Methylprednisolone—asthma	1.35e-05	9.98e-05	CcSEcCtD
Gliclazide—Body temperature increased—Prednisone—asthma	1.35e-05	9.97e-05	CcSEcCtD
Gliclazide—Abdominal pain—Prednisone—asthma	1.35e-05	9.97e-05	CcSEcCtD
Gliclazide—ALB—Hemostasis—IL3—asthma	1.35e-05	0.000312	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—STAT3—asthma	1.35e-05	0.000312	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—BDKRB2—asthma	1.35e-05	0.000311	CbGpPWpGaD
Gliclazide—Diarrhoea—Betamethasone—asthma	1.34e-05	9.91e-05	CcSEcCtD
Gliclazide—Diarrhoea—Dexamethasone—asthma	1.34e-05	9.91e-05	CcSEcCtD
Gliclazide—ABCC8—Metabolism—GSTM1—asthma	1.33e-05	0.000309	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PLA2G4A—asthma	1.33e-05	0.000309	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SERPINE1—asthma	1.33e-05	0.000307	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—asthma	1.32e-05	0.000306	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—asthma	1.32e-05	0.000305	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LTA4H—asthma	1.31e-05	0.000302	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADCY2—asthma	1.3e-05	0.000301	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL3—asthma	1.3e-05	0.0003	CbGpPWpGaD
Gliclazide—Dizziness—Dexamethasone—asthma	1.3e-05	9.58e-05	CcSEcCtD
Gliclazide—Dizziness—Betamethasone—asthma	1.3e-05	9.58e-05	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—PLA2G4A—asthma	1.29e-05	0.000299	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GSTM1—asthma	1.29e-05	0.000299	CbGpPWpGaD
Gliclazide—Nausea—Triamcinolone—asthma	1.28e-05	9.48e-05	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—RHOA—asthma	1.28e-05	0.000297	CbGpPWpGaD
Gliclazide—Nausea—Methylprednisolone—asthma	1.28e-05	9.46e-05	CcSEcCtD
Gliclazide—ALB—Hemostasis—KNG1—asthma	1.27e-05	0.000295	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ARG1—asthma	1.27e-05	0.000294	CbGpPWpGaD
Gliclazide—Hypersensitivity—Prednisone—asthma	1.26e-05	9.29e-05	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—TGFB1—asthma	1.25e-05	0.000289	CbGpPWpGaD
Gliclazide—Vomiting—Betamethasone—asthma	1.25e-05	9.21e-05	CcSEcCtD
Gliclazide—Vomiting—Dexamethasone—asthma	1.25e-05	9.21e-05	CcSEcCtD
Gliclazide—Rash—Betamethasone—asthma	1.24e-05	9.13e-05	CcSEcCtD
Gliclazide—Rash—Dexamethasone—asthma	1.24e-05	9.13e-05	CcSEcCtD
Gliclazide—Dermatitis—Dexamethasone—asthma	1.24e-05	9.12e-05	CcSEcCtD
Gliclazide—Dermatitis—Betamethasone—asthma	1.24e-05	9.12e-05	CcSEcCtD
Gliclazide—ABCC8—Metabolism—PPP2CA—asthma	1.23e-05	0.000284	CbGpPWpGaD
Gliclazide—Headache—Dexamethasone—asthma	1.23e-05	9.07e-05	CcSEcCtD
Gliclazide—Headache—Betamethasone—asthma	1.23e-05	9.07e-05	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—TGFB1—asthma	1.23e-05	0.000283	CbGpPWpGaD
Gliclazide—Asthenia—Prednisone—asthma	1.23e-05	9.05e-05	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—EGFR—asthma	1.22e-05	0.000283	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—KNG1—asthma	1.22e-05	0.000283	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AGTR1—asthma	1.22e-05	0.000281	CbGpPWpGaD
Gliclazide—Pruritus—Prednisone—asthma	1.21e-05	8.92e-05	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—PPP2CA—asthma	1.19e-05	0.000276	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LTA4H—asthma	1.19e-05	0.000275	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL10—asthma	1.19e-05	0.000275	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ADCY2—asthma	1.17e-05	0.000271	CbGpPWpGaD
Gliclazide—Diarrhoea—Prednisone—asthma	1.17e-05	8.63e-05	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—TNF—asthma	1.17e-05	0.00027	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NTRK1—asthma	1.17e-05	0.00027	CbGpPWpGaD
Gliclazide—Nausea—Dexamethasone—asthma	1.16e-05	8.6e-05	CcSEcCtD
Gliclazide—Nausea—Betamethasone—asthma	1.16e-05	8.6e-05	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—ADRB2—asthma	1.15e-05	0.000267	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALDH7A1—asthma	1.15e-05	0.000266	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ARG1—asthma	1.14e-05	0.000264	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—ITPR1—asthma	1.14e-05	0.000263	CbGpPWpGaD
Gliclazide—Dizziness—Prednisone—asthma	1.13e-05	8.34e-05	CcSEcCtD
Gliclazide—ALB—Metabolism—ARG2—asthma	1.1e-05	0.000255	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ITPR1—asthma	1.09e-05	0.000252	CbGpPWpGaD
Gliclazide—Vomiting—Prednisone—asthma	1.09e-05	8.02e-05	CcSEcCtD
Gliclazide—Rash—Prednisone—asthma	1.08e-05	7.95e-05	CcSEcCtD
Gliclazide—Dermatitis—Prednisone—asthma	1.08e-05	7.95e-05	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2—asthma	1.08e-05	0.000249	CbGpPWpGaD
Gliclazide—Headache—Prednisone—asthma	1.07e-05	7.9e-05	CcSEcCtD
Gliclazide—ALB—Hemostasis—PLA2G4A—asthma	1.06e-05	0.000245	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CSF2—asthma	1.05e-05	0.000243	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ARG1—asthma	1.04e-05	0.000241	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CD86—asthma	1.04e-05	0.00024	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALDH7A1—asthma	1.03e-05	0.000239	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EDN1—asthma	1.03e-05	0.000239	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL5—asthma	1.02e-05	0.000237	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PLA2G4A—asthma	1.02e-05	0.000236	CbGpPWpGaD
Gliclazide—Nausea—Prednisone—asthma	1.01e-05	7.49e-05	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—CSF2—asthma	1.01e-05	0.000233	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ARG2—asthma	9.89e-06	0.000229	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—HMOX1—asthma	9.86e-06	0.000228	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SMAD3—asthma	9.81e-06	0.000227	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PPP2CA—asthma	9.77e-06	0.000226	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	9.66e-06	0.000223	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2RA—asthma	9.46e-06	0.000219	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—POMC—asthma	9.43e-06	0.000218	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—asthma	9.41e-06	0.000218	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALDH7A1—asthma	9.41e-06	0.000218	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PPP2CA—asthma	9.39e-06	0.000217	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCR5—asthma	9.22e-06	0.000213	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—POMC—asthma	9.14e-06	0.000212	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VEGFA—asthma	9.14e-06	0.000211	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALOX15—asthma	9.13e-06	0.000211	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALOX5AP—asthma	9.13e-06	0.000211	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PDGFB—asthma	9.13e-06	0.000211	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2RA—asthma	9.09e-06	0.00021	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ARG2—asthma	9.02e-06	0.000209	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—C3—asthma	9.01e-06	0.000208	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PLAU—asthma	8.86e-06	0.000205	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CDK2—asthma	8.86e-06	0.000205	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PDGFB—asthma	8.77e-06	0.000203	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CHAT—asthma	8.71e-06	0.000201	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	8.67e-06	0.000201	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALB—asthma	8.6e-06	0.000199	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—asthma	8.39e-06	0.000194	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LEP—asthma	8.39e-06	0.000194	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALB—asthma	8.34e-06	0.000193	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—FN1—asthma	8.23e-06	0.00019	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NOS3—asthma	8.22e-06	0.00019	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALOX5AP—asthma	8.2e-06	0.00019	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALOX15—asthma	8.2e-06	0.00019	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS2—asthma	8.14e-06	0.000188	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NOS3—asthma	7.98e-06	0.000184	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FN1—asthma	7.91e-06	0.000183	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	7.91e-06	0.000183	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CHAT—asthma	7.82e-06	0.000181	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALOX5—asthma	7.76e-06	0.00018	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—asthma	7.52e-06	0.000174	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALOX5AP—asthma	7.47e-06	0.000173	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALOX15—asthma	7.47e-06	0.000173	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CARM1—asthma	7.41e-06	0.000171	CbGpPWpGaD
Gliclazide—ALB—Metabolism—DCN—asthma	7.3e-06	0.000169	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—asthma	7.29e-06	0.000169	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—POMC—asthma	7.2e-06	0.000167	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CHAT—asthma	7.13e-06	0.000165	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ALDH2—asthma	7.1e-06	0.000164	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL2—asthma	7.05e-06	0.000163	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6R—asthma	7.03e-06	0.000163	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALOX5—asthma	6.97e-06	0.000161	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SERPINE1—asthma	6.85e-06	0.000158	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—POMC—asthma	6.83e-06	0.000158	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTT1—asthma	6.75e-06	0.000156	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CARM1—asthma	6.65e-06	0.000154	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—RHOA—asthma	6.61e-06	0.000153	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SERPINE1—asthma	6.58e-06	0.000152	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTEN—asthma	6.56e-06	0.000152	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—DCN—asthma	6.55e-06	0.000152	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS3—asthma	6.54e-06	0.000151	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALDH2—asthma	6.37e-06	0.000147	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTEN—asthma	6.36e-06	0.000147	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALOX5—asthma	6.35e-06	0.000147	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RHOA—asthma	6.35e-06	0.000147	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOS3—asthma	6.28e-06	0.000145	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	6.13e-06	0.000142	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTT1—asthma	6.06e-06	0.00014	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CARM1—asthma	6.06e-06	0.00014	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DCN—asthma	5.97e-06	0.000138	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALDH2—asthma	5.81e-06	0.000134	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NQO1—asthma	5.61e-06	0.00013	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	5.59e-06	0.000129	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	5.59e-06	0.000129	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL8—asthma	5.57e-06	0.000129	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2—asthma	5.54e-06	0.000128	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTT1—asthma	5.53e-06	0.000128	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADCY2—asthma	5.49e-06	0.000127	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—asthma	5.45e-06	0.000126	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2—asthma	5.33e-06	0.000123	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	5.1e-06	0.000118	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP9—asthma	5.04e-06	0.000117	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NQO1—asthma	5.04e-06	0.000117	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTEN—asthma	5.01e-06	0.000116	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADCY2—asthma	4.93e-06	0.000114	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.89e-06	0.000113	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTEN—asthma	4.75e-06	0.00011	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—asthma	4.71e-06	0.000109	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTP1—asthma	4.68e-06	0.000108	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMOX1—asthma	4.62e-06	0.000107	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ITPR1—asthma	4.61e-06	0.000107	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NQO1—asthma	4.59e-06	0.000106	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAT—asthma	4.56e-06	0.000105	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADCY2—asthma	4.5e-06	0.000104	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—STAT3—asthma	4.48e-06	0.000104	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.46e-06	0.000103	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—asthma	4.32e-06	0.0001	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTM1—asthma	4.3e-06	9.95e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PLA2G4A—asthma	4.3e-06	9.95e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	4.26e-06	9.86e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTP1—asthma	4.2e-06	9.72e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—asthma	4.15e-06	9.61e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMOX1—asthma	4.14e-06	9.59e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ITPR1—asthma	4.14e-06	9.57e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAT—asthma	4.09e-06	9.46e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EGFR—asthma	4.07e-06	9.42e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPP2CA—asthma	3.96e-06	9.17e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	3.89e-06	8.99e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTM1—asthma	3.86e-06	8.93e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PLA2G4A—asthma	3.86e-06	8.93e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTP1—asthma	3.83e-06	8.86e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMOX1—asthma	3.78e-06	8.74e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ITPR1—asthma	3.77e-06	8.72e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAT—asthma	3.73e-06	8.63e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPP2CA—asthma	3.56e-06	8.23e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PLA2G4A—asthma	3.52e-06	8.15e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTM1—asthma	3.52e-06	8.15e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPP2CA—asthma	3.24e-06	7.5e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—asthma	3.13e-06	7.24e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—POMC—asthma	3.04e-06	7.03e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—POMC—asthma	2.73e-06	6.31e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NOS3—asthma	2.65e-06	6.13e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—POMC—asthma	2.49e-06	5.76e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALB—asthma	2.49e-06	5.76e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—asthma	2.43e-06	5.61e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NOS3—asthma	2.38e-06	5.51e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALB—asthma	2.27e-06	5.25e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—asthma	2.18e-06	5.04e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NOS3—asthma	2.17e-06	5.02e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTEN—asthma	2.12e-06	4.89e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—asthma	1.99e-06	4.59e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTEN—asthma	1.9e-06	4.39e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTEN—asthma	1.73e-06	4e-05	CbGpPWpGaD
